Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

BNTX

BioNTech SE ADR

Nov 26 • 04:00PM ET

102.70

+2.99 3.00 %

Healthcare • Biotechnology • Germany • NASD

Nov 26, 7:35 AMBioNTech today announced CureVac shareholders approved proposals for its exchange offer and disclosed an exchange ratio of 0.05363 BioNTech ADS per CureVac share (assuming a Dec. 3, 9:00 a.m. ET expiration).

Peers: MRNA PFE NVAX AZN JNJ GSK BMY GILD LLY SNY

| Held by: IBB FBT FNDF TCAF SPDW BBH BBEU IDNA QQQJ BBIN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.63	Insider Own	0.69%	Shs Outstand	240.46M	Perf Week	1.25%
Market Cap	24.70B	Forward P/E	-	EPS next Y	-3.06	Insider Trans	0.00%	Shs Float	238.79M	Perf Month	-2.22%
Enterprise Value	8.09B	PEG	-	EPS next Q	-0.25	Inst Own	21.44%	Short Float	2.52%	Perf Quarter	0.76%
Income	-632.88M	P/S	6.99	EPS this Y	-26.89%	Inst Trans	-2.43%	Short Ratio	6.39	Perf Half Y	2.44%
Sales	3.53B	P/B	1.14	EPS next Y	24.95%	ROA	-2.53%	Short Interest	6.03M	Perf YTD	-9.87%
Book/sh	90.29	P/C	1.46	EPS next 5Y	-7.75%	ROE	-2.94%	52W High	129.27 -20.55%	Perf Year	-9.22%
Cash/sh	70.26	P/FCF	-	EPS past 3/5Y	- -25.87%	ROIC	-2.89%	52W Low	81.20 26.48%	Perf 3Y	-35.17%
Dividend Est.	-	EV/EBITDA	43.04	Sales past 3/5Y	-49.00% 89.57%	Gross Margin	82.79%	Volatility	4.29% 3.53%	Perf 5Y	9.63%
Dividend TTM	-	EV/Sales	2.29	EPS Y/Y TTM	-25.24%	Oper. Margin	-6.70%	ATR (14)	3.66	Perf 10Y	-
Dividend Ex-Date	Jun 02, 2022	Quick Ratio	7.02	Sales Y/Y TTM	7.04%	Profit Margin	-17.92%	RSI (14)	50.47	Recom	1.57
Dividend Gr. 3/5Y	- -	Current Ratio	7.12	EPS Q/Q	-115.68%	SMA20	-0.19%	Beta	1.30	Target Price	142.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	29.80%	SMA50	-0.13%	Rel Volume	1.11	Prev Close	99.71
Employees	6772	LT Debt/Eq	0.01	Earnings	Nov 03 BMO	SMA200	-1.65%	Avg Volume	942.87K	Price	102.70
IPO	Oct 10, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	87.51% 108.91%	Trades		Volume	1,046,067	Change	3.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-25	Reiterated	H.C. Wainwright	Buy	$134 → $145
May-29-25	Initiated	Goldman	Neutral	$110
Mar-13-25	Initiated	Citigroup	Buy	$145
Jan-10-25	Initiated	Truist	Buy	$172
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99
Oct-16-23	Downgrade	HSBC Securities	Buy → Hold	$124 → $111
Jul-14-23	Initiated	HSBC Securities	Buy	$124

Show Previous Ratings

Nov-26-25 07:30AM	BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration (GlobeNewswire)
Nov-19-25 09:42PM	Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? (Barchart)
Nov-17-25 08:58AM	BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ (Zacks)
Nov-14-25 06:41AM	Pfizer Cuts BioNTech Stake by More Than Half (GuruFocus.com)
Nov-13-25 01:24PM	Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up (GuruFocus.com) -7.00%
06:23AM	Loading…
06:23AM	CPHI 2025: handprint metric bridges pharma sustainability and economic value (Pharmaceutical Technology)
Nov-05-25 11:41AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-03-25 02:01PM	BioNTech SE (BNTX) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Investments (GuruFocus.com)
07:13AM	BioNTech Boosts FY25 Revenue Outlook - Update (RTT News)
06:45AM	BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update (GlobeNewswire)
Oct-30-25 10:32AM	BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View (Zacks)
09:56AM	Singapore Approves Latest Pfizer/BioNTech COVID-19 Vaccine for All Ages (Insider Monkey)
Oct-28-25 01:25PM	3 Stocks Under $30: Where to Put $1,000 to Work Today (24/7 Wall St.)
07:45AM	BioNTech to Host Innovation Series R&D Day on November 11, 2025 (GlobeNewswire)
Oct-27-25 09:17AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings? (Zacks)
07:45AM	Loading…
07:45AM	BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025 (GlobeNewswire)
Oct-22-25 06:45AM	BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V. (GlobeNewswire)
Oct-20-25 10:15AM	Pfizer's Q3 Non-Oncology Performance: Here's What to Expect (Zacks)
Oct-17-25 08:40AM	Euronext backs German push for single European stock exchange (Euronews)
Oct-14-25 05:27PM	R&D spending now can have big payoffs later for companies (TheStreet)
10:01AM	BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? (Zacks)
Oct-08-25 10:15AM	Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead (Motley Fool)
Oct-02-25 10:32AM	Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? (Zacks)
Oct-01-25 06:13PM	Why BioNTech Stock Jumped by Nearly 4% on Wednesday (Motley Fool)
Sep-24-25 09:43AM	BMY Reports Positive Data From a Late-Stage Multiple Myeloma Study (Zacks)
Sep-23-25 06:45AM	BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025 (GlobeNewswire)
Sep-22-25 06:45PM	Why BioNTech Stock Bumped Higher Today (Motley Fool)
09:54AM	Analyst Report: BioNTech SE (Morningstar Research)
Sep-19-25 04:24PM	CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids (Investor's Business Daily)
Sep-18-25 01:53PM	The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut (Investor's Business Daily)
08:45AM	Loading…
08:45AM	Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises (PR Newswire)
Sep-17-25 10:04AM	MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response (Zacks)
Sep-15-25 08:56AM	COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths (Zacks)
04:00AM	Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics? (Pharma Voice)
Sep-14-25 01:16AM	BMO Capital Maintains a Buy on BioNTech SE (BNTX) (Insider Monkey)
Sep-13-25 01:56PM	Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths (FastCompany)
Sep-12-25 07:43PM	Drugmakers Fall on Report US to Claim Covid Shot Killed Kids (Bloomberg) -7.26%
06:19PM	Why BioNTech Stock Sank by More Than 7% Today (Motley Fool)
04:21PM	Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
02:11PM	Vaccine Stocks Down Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
01:37PM	COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says (MarketWatch)
12:33PM	Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths (Investing.com)
12:11PM	Trump officials to link child deaths to COVID shots, Washington Post reports (Reuters)
11:35AM	Stock Market Today: Investors await opening trade from Gemini, Via, and Legence (TheStreet)
09:08AM	BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? (Zacks)
Sep-11-25 01:01PM	Bristol Myers Squibb, BioNTech Announce Positive Interim Data from Phase 2 Trial of Pumitamig in Lung Cancer (Insider Monkey)
09:52AM	Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? (Zacks)
Sep-09-25 01:17PM	SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study (Zacks)
Sep-08-25 06:12PM	Today's Moving Stocks: Planet Labs, EchoStar, Robinhood, Summit Therapeutics, BioNTech, CVS Health (TheStreet) -8.71%
04:08PM	Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch (Investor's Business Daily)
01:41PM	Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective (Barrons.com)
11:26AM	Stock Market Today: Stocks rise as investors embrace supersized cut chances (TheStreet)
11:00AM	First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity (GlobeNewswire)
06:45AM	Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula (Business Wire)
Sep-05-25 04:41PM	Why BioNTech Stock Crushed the Market Today (Motley Fool) +8.66%
01:46PM	BioNTech and Dualitys ADC trumps Kadcyla, but analysts unimpressed (Clinical Trials Arena)
12:22PM	Analyst Report: BioNTech SE (Morningstar Research)
10:27AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
09:27AM	BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb (Investor's Business Daily)
09:09AM	BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data (Benzinga)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)
Aug-28-25 07:55AM	FDA approves mRNA vaccines for new Covid-19 season amid political tension (Pharmaceutical Technology)
04:53AM	BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal (Insider Monkey)
Aug-27-25 02:30PM	RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. (Investor's Business Daily)
01:42PM	New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. (The Wall Street Journal)
12:50PM	Pfizer and BioNTechs COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 (Business Wire)
Aug-26-25 08:31PM	Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' (Benzinga)
Aug-11-25 05:15AM	NHS England to expand trial access for head and neck cancer vaccine (Clinical Trials Arena)
04:19AM	GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic (Investing.com)
Aug-08-25 07:54AM	BioNTech ends patent fight with mRNA rival CureVac ahead of buyout deal (BioPharma Dive)
04:01AM	Bio/Pharmaceutical Outsourcing Analysis Report, June 2025 Edition - ADCs on the Rise: MilliporeSigma, Lonza Invest in Manufacturing While BioNTech Adds CMOs Ahead of FDA Filing (GlobeNewswire)
03:31AM	GSK to Receive $370 Million in U.S. Patent Litigation Settlement (The Wall Street Journal)
Aug-06-25 09:18AM	BMY Stock Trades Near 52-Week Low: Time to Buy or Sell? (Zacks)
Aug-05-25 11:55AM	BioNTech price target raised to $185 from $181 at Clear Street (TipRanks)
11:47AM	Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth (Zacks)
06:00AM	Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 (GlobeNewswire)
03:00AM	BioNTech SE (BNTX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
Aug-04-25 11:16PM	Analyst Report: BioNTech SE (Morningstar Research)
08:51AM	J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal? (Zacks)
07:01AM	BioNTech Stock Rises as Drug Maker Beats Earnings Expectations. (Barrons.com)
06:51AM	BioNTech's Q2 revenues double on higher COVID vaccine sales (Reuters)
06:45AM	BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update (GlobeNewswire)
Aug-03-25 02:00PM	Palantir, Advanced Micro, Walt Disney, Pfizer, ZoomInfo, and More Stocks to Watch This Week (Barrons.com)
Aug-01-25 01:21PM	MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View (Zacks)
11:23AM	Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
10:01AM	Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings (Zacks)
08:44AM	Moderna's Key Patent Win Overshadowed By Gloomy Outlook (Benzinga)
Jul-31-25 12:18PM	Arm Holdings slips on guidance, AbbVie Q2 beat, Bristol-Myers outlook (Yahoo Finance Video)
11:43AM	Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View (Zacks)
10:42AM	Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion (Benzinga)
08:57AM	Bristol Myers Beats Earnings Expectations. Its Still Optimistic About New Schizophrenia Drug. (Barrons.com)
07:57AM	Bristol Myers Squibb Cuts Full-Year Adjusted View, But Raises Revenue Expectations (The Wall Street Journal)
07:48AM	Bristol-Myers Squibb shares rise as Q2 results boosted by growth portfolio (Investing.com)
07:01AM	Bristol Myers posts better-than-expected second quarter results on strength of top sellers (Reuters)
Jul-30-25 12:00PM	BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know (Zacks)
11:07AM	Perrigo to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
04:31AM	Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - OncoTherapy Science, Inovio, BioNTech, Theravectys, and GlaxoSmithKline (GlobeNewswire)
Jul-29-25 10:00AM	Best Momentum Stocks to Buy for July 29th (Zacks)
08:26AM	Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock? (Zacks)
06:52AM	New Strong Buy Stocks for July 29th (Zacks)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Medine GmbH	Officer	Nov 13 '25	Proposed Sale	111.70	1,114,130	124,448,321	Nov 13 08:23 AM
Jeggle Helmut Wolfgang	Director	Nov 05 '25	Proposed Sale	103.43	150,000	15,514,500	Nov 05 04:52 PM
ATHOS KG	10% Owner	Sep 05 '25	Proposed Sale	112.46	500,000	56,230,000	Sep 05 04:41 PM
Medine GmbH	Officer	Aug 15 '25	Proposed Sale	112.70	1,774,837	200,024,130	Aug 15 08:27 AM
Tureci Ozlem	Officer	Aug 15 '25	Proposed Sale	112.70	185,001	20,849,613	Aug 15 08:22 AM
Jeggle Helmut Wolfgang	Director	Jun 04 '25	Proposed Sale	113.10	150,000	16,965,000	Jun 04 08:31 AM
ATHOS KG	10% Owner	Jun 02 '25	Proposed Sale	110.83	175,000	19,394,800	Jun 02 04:08 PM
ATHOS KG	10% Owner	May 28 '25	Proposed Sale	98.68	500,000	49,340,000	May 28 09:00 AM
Jeggle Helmut Wolfgang	Director	May 07 '25	Proposed Sale	94.74	150,000	14,211,000	May 07 07:30 AM
Richardson Ryan	Officer	Feb 27 '25	Proposed Sale	114.00	26,500	3,021,000	Feb 27 07:57 AM
Medine GmbH	Officer	Feb 20 '25	Proposed Sale	119.58	1,000,000	119,580,000	Feb 20 07:53 AM
Poetting Sierk	Officer	Feb 20 '25	Proposed Sale	119.58	120,000	14,349,600	Feb 20 07:50 AM
ATHOS KG	10% Owner	Dec 13 '24	Proposed Sale	120.69	4,983	601,398	Dec 13 05:56 PM
ATHOS KG	10% Owner	Dec 11 '24	Proposed Sale	116.85	22,450	2,623,283	Dec 11 05:25 PM
ATHOS KG	10% Owner	Dec 09 '24	Proposed Sale	121.72	53,716	6,538,312	Dec 09 06:35 PM
ATHOS KG	10% Owner	Dec 06 '24	Proposed Sale	118.84	13,104	1,557,279	Dec 06 05:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

BNTX

BioNTech SE ADR

Upgrade your FINVIZ experience